Newsfeed PEGPH20: Future Directions in Pancreatic Adenocarcinoma author Let's Win! Pancreatic Cancer 4 January, 2018 Andrew Ko, MD, provides his perspective on PEGPH20 given the phase III HALO-301 trial and potential drug combinations in the setting of pancreatic adenocarcinoma. Watch video here . . . Related Stories Newsfeed Risk Factors Related to Age at Diagnosis of Pancreatic Cancer: a Retrospective Cohort Pilot StudyLet's Win! Pancreatic Cancer Newsfeed Pancreatic Cancer: New hope for Effective Treatment after Scientific Breakthrough in Identifying CausesLet's Win! Pancreatic Cancer Newsfeed Neoadjuvant Chemoradiotherapy Extends OS vs. Upfront Surgery in Pancreatic Cancer SubsetsLet's Win! Pancreatic Cancer